PMID: 8601646Apr 1, 1996Paper

Understanding and evaluating clinical trials

Journal of the American Academy of Dermatology
M Bigby, A S Gadenne

Abstract

In this review, we attempt to provide the basic knowledge necessary to understand and evaluate clinical trials because properly conducted, randomized clinical trials are the best sources for determining the best available treatment. Other commonly used sources rarely provide sufficient detail necessary to determine the efficacy and safety of any treatment, and they often contain biases or pitfalls that make them unacceptable or unreliable. Our method for reviewing clinical trials allows a busy clinician to use his or her time most efficiently by deciding not to read the majority of poorly conceived, designed, executed, or reported trials and those trials with insignificant results. It provides a means to determine the quality of the trials that one does decide to read and to retain and retrieve the information when it is needed. The method involves recognizing and evaluating the features that strengthen clinical trials and help validate their conclusions. These features include proper selection and allocation of patients, inclusion of an appropriate control group, randomization, prior selection of clinically and biologically important outcome variables, blinding of assessment, consideration of patient compliance and drop out, a...Continue Reading

References

Apr 1, 1978·International Journal of Dermatology·A M Allen
Aug 1, 1977·Archives of Dermatology·A R AhmedT T Provost
Dec 14, 1978·The New England Journal of Medicine·K J Rothman
Aug 17, 1979·JAMA : the Journal of the American Medical Association·T A HutchinsonA R Feinstein
Nov 2, 1979·JAMA : the Journal of the American Medical Association·J M LeventhalA R Feinstein
Jan 1, 1978·International Journal of Dermatology·A M Allen
Feb 13, 1975·The New England Journal of Medicine·C L Rümke
Dec 22, 1975·JAMA : the Journal of the American Medical Association·F E Karch, L Lasagna
Oct 15, 1992·The New England Journal of Medicine·L A BeroD Rennie
Jun 1, 1992·Annals of Internal Medicine·M S WilkesM F Shapiro
Jul 1, 1991·The British Journal of Surgery·G D Murray
Jul 1, 1991·The British Journal of Surgery·G D Murray
Mar 9, 1990·JAMA : the Journal of the American Medical Association·M J Gardner, J Bond
Jan 1, 1987·Journal of Chronic Diseases·A R Feinstein
Jul 1, 1986·Annals of Internal Medicine·R B HaynesD L Sackett
Jun 1, 1986·The American Journal of Medicine·W C Ehmann, R Silber
Mar 1, 1985·Basic Research in Cardiology·E Szczepańska-SadowskaE Simon
Mar 9, 1970·JAMA : the Journal of the American Medical Association·W H EaglsteinJ A Brown
Sep 12, 1970·British Medical Journal·N D Lionel, A Herxheimer
Jan 1, 1980·International Journal of Dermatology·A M Allen
Jan 5, 1984·The New England Journal of Medicine·J R QuesadaJ U Gutterman
Jun 1, 1984·Journal of the American Academy of Dermatology·E GonzalezS Freedman
Jul 1, 1982·The American Journal of Medicine·J AvornR Hartley
Nov 4, 1982·The New England Journal of Medicine
May 1, 1981·Controlled Clinical Trials·T C ChalmersA Ambroz
Mar 1, 1980·International Journal of Dermatology·A M Allen
Jan 1, 1995·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·D F Cella
Apr 26, 1995·JAMA : the Journal of the American Medical Association·M G ZieglerB C Singer
Jul 6, 1995·The New England Journal of Medicine·T L MeinkingF A Kerdel
Jul 13, 1994·JAMA : the Journal of the American Medical Association·M K Cho, L A Bero
Jul 13, 1994·JAMA : the Journal of the American Medical Association·P A RochonT C Chalmers
Jul 13, 1994·JAMA : the Journal of the American Medical Association·D MoherG A Wells
Sep 1, 1994·Journal of the American Academy of Dermatology·R B StrickerW L Epstein
Sep 1, 1994·Journal of the American Academy of Dermatology·A C Huntley
May 25, 1994·JAMA : the Journal of the American Medical Association·M LevineV Moyer

❮ Previous
Next ❯

Citations

Apr 25, 2009·BMC Complementary and Alternative Medicine·Tannis JurgensLindsay Lord
Jan 1, 2010·The Journal of Investigative Dermatology·Phyllis I SpulsTamar Nijsten
Nov 11, 2008·Statistics in Medicine·Geoff Cumming
Oct 17, 2006·Clinical and Experimental Dermatology·V SchoderK P Wilhelm
Dec 21, 2004·Biometrics·Allan DonnerGuangyong Zou
May 3, 2000·Dermatologic Clinics·M Bigby
Apr 22, 2004·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Marvin J Rapaport
Sep 1, 1999·The British Journal of Dermatology·D M AshcroftC E Griffiths
Feb 22, 2011·Clinical Trials : Journal of the Society for Clinical Trials·Mohamed M ShoukriAllan Donner
Jun 1, 1997·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·S J Salasche
Jul 25, 2003·Journal of Cutaneous Medicine and Surgery·Aditya K GuptaRichard C Summerbell
Feb 3, 2004·The Journal of Dermatological Treatment·A K GuptaA Johnson
Aug 26, 2015·Statistical Methods in Medical Research·Hong ZhuChul Ahn
Mar 29, 2005·Journal of the American Academy of Dermatology·David A BarzilaiEliot N Mostow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Academy of Dermatology
B G Howard
Dermatology : International Journal for Clinical and Investigative Dermatology
Luigi Naldi, Jean-Hilaire Saurat
© 2021 Meta ULC. All rights reserved